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URETHANE has been shown to induce the initiating phase ofskin carcinogenesis
in mice, not only when applied locally (Graffi, Vlamynch, Hoffmann, and Schulz,
1953; Salaman and Roe, 1953; Roe and Salaman, 1954; Berenblum and
Haran, 1955b), but also when administered by mouth (Haran and Berenblum,
1956). The fact that urethane (ethyl carbamate) has a relatively simple chemical
structure, is water-soluble, is itself non-carcinogenic for skin epithelium in the
mouse, and does not even elicit epithelial hyperplasia, or any other demonstrable
evidence of skin irritation-so constant a feature of other initiating agents or
skin carcinogens, renders it all the more attractive a tool for the study of the
nature of initiating action.
Before one could effectively exploit urethane for this purpose, some quantita-
tive data were needed about the conditions under which its systemic initiating
action operated. The results of such a quantitative study, presented here, are
concerned with (a) variations in total dose ofurethane, given once only by mouth;
(b) different numbers of urethane feedings, totalling the same overall dose; (c)
different routes of administration of urethane, e.g. by mouth, intraperitoneally,
subcutaneously, and topically applied to the skin; and (d) variations in the
interval between the end of initiating action (urethane by mouth) and the
commencement of promoting action (croton oil applied repeatedly to a small
area of skin).
METHODS
The animals used in these experiments were male and female mice of the
Swiss strain, bred in these laboratories by brother-sister mating for 16-15 genera-
tions. They were 2-3 months old at the start of the experiment, housed in an
air-conditioned room at 21-23' C, and fed on Purina Laboratory Chow, and water
ad libitum. The urethane was made up as a 5 per cent solution in distilled water,
for oral, subcutaneous, and intraperitoneal administration, and as a 40 per cent
solution in acetone, for skin application. The oral administration was by means
of a polyethylene stomach tube, as previously described (Berenblum and Haran,
1955a). The promoting action with croton oil was standardized for the whole
series of experiments described here, consisting of applications, with a glass rod,
ofa 5per cent solution inliquidparaffin, limited to a small area (about 1.5 x 2 cm.)
in the dorsal region ofthe back, the procedure repeated twice-weekly for 26 weeks.
The resulting skin tumours were charted at their first appearance, and fort-
nightly thereafter. Papillomas that regressed within 2 weeks of their firstI. BERENBLUM AND NECHAMA HARAN-GHERA
appearance were not listed in the final records. Careful note was also taken at
autopsy of the numbers of adenomas of the lungs in each animal.
RESULTS
1. Effect of dose of urethane, administered orally, as initiating agent
The effects of single feedings of urethane, containing 1, 4, 16, and 64 mg.,
respectively, followed in each case by twice-weekly applications of croton oil to
the skin, are summarized in Table I. An increased response with increased
dosage is clearly demonstrated in the form of (a) percentage of animals bearing
papillomas, and (b) average number of papillomas per animal, and also of (c)
percentage of mice bearing lung adenomas, and (d) the average number of lung
adenomas per animal. On the otherhand, the averagelatent period forpapilloma
production, though varying from group to group with the shortest latent period
for the highest dose, showed no consistent correlation with dosage.
TABLE I.-Effect qf Dose of Urethane (Single Feeding), followed by
Standard Croton Oil Treatment, on Tumour Induction
Tumours of lungs
Tumours of skin -
s--r~~~ - 5 Average
Mice Average Average Mice number
bearing number latent bearing adenomas
Initiating Promoting papillomas/! papillomas period* adenomas/! per
agent agent survivors per mouse. (weeks) survivors mouse
Urethane 64 mg.. Croton oil 24/24 100% 5.0-0 7 8 . 24/24 100% 7 040 9
,, 16mg . ,, 15/24 62.5% 1-2i0-3 14j 18/24 75% 1'6i0'2
,, 4mg . ,, . 6/14 43% 0'4i0'2 20j . 3/14 21% 0-3±0-2 ,, 1 mg .... 3/24 12.5% 0'25±0-1 16 4/24 17/o 0-2-0'1
(control) . ,, . 2/20 10% 0'1±0'07 15* . 1/20 5% 0 05±0-005
Urethane administered as a 5 per cent solution in distilled water by stomach tube.
Croton oil applied repeatedly to the skin (twice-weekly for 26 weeks), as a 5 per cent solution in
liquid paraffin, by means of a glass rod.
Interval between initiating action and commencement of promoting action: 3 days.
* For first tumours.
While the lung tumour incidence, even in the group with the lowest dose of
urethane (1 mg.), was significantly higher than the spontaneous incidence in the
control group (without urethane), the difference for skin tumours between the
group receiving only 1 mg. urethane and the control seems too small to be signifi-
cant. The minimal effective dose of urethane per os for skin initiating action
would, therefore, seem to lie somewhere between 1 and 4 mg.
2. Different numbers of urethane feedings, totalling the same overall dose
The total overall dose ofurethane chosen for this experiment was the maximum
tolerated dose, for our mice, when given per os, namely, 64 mg. This was
administered as a single dose of 64 mg., as two doses of 32 mg., as 5 doses of 13
mg., and as 20 doses of 3.2 mg., respectively, the interval between the successive
feedings being half a week. This treatment was followed, after a further interval
of 3 days, by twice-weekly applications of croton oil for 26 weeks.
The results (Table II) are somewhat ambiguous, in that the first two groups
(receiving one and two doses respectively) showed a high incidence ofskin tumours
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per animal and also of lung tumours, while the other two (receiving 5 and 20
doses) showed a relatively low incidence for both types of tumours; yet no
consistent progression in response, in passing from 1 to 20 doses, was discernible.
TABLEII.-Effect of Divided Doses of Urethane per os, followed by Standard
Croton Oil Treatment on the Skin, on Tumour Induction
Initiating
agent
Urethane
64 mg. x 1
32 mg. x 2
13mg. x 5
3-2 mg. x 20
Tumours of skin
--
Mice Average Average
bearing number latent
Promoting papillomas/ papillomas period
agent survivors per mouse (weeks)
Croton oil
,,9
,,9
. 24/24 100%
. 37/37 100%
. 17/20 85%
· 21/24 87.5%
5 0i0 7
8-.00-07
2-6±0-6
2-2i0-4
8
6
10o
11
Tumours of lungs
Average
3~ Mice number
bearing adenomas
adenomas/ per
survivors mouse
24/24 100% 7 -0i0±0 9
36/37 97%0/ 9'0±0'5
13/20 65% 1*7i0-4 · 20/24 83% 3-3±0.8
Details of method, as in Table I.
3. Urethane action by oral, subcutaneous, and interperitoneal routes
The maximum tolerated dose per os (64 mg.) was found to cause some deaths
when given intraperitoneally. The somewhat smaller dose of 50 mg. was, there-
fore, chosen for both intraperitoneal and subcutaneous injections. In spite of
this slight discrepancy in dosage, when compared with that used orally, it seems
clear (Table III) that the dose of urethane, both for initiating action on skin and
for complete carcinogenic action on the lung, is of the same order of magnitude
for the three routes-orally, intraperitoneally, and subcutaneously.
TABLE III.-Effect of Route ofAdministration of Urethane, followed by
Standard Croton Oil Treatment on Skin, on Tumour Induction
Tumours of skin
Initiating
agent
(urethane)
(single
dose)
64 mg. per os .
50 mg. intra-
peritoneally
50 mg. subcu-
taneously
Promoting
agent
Croton oil
Mice
bearing
papillomas/
survivors
24/24 100%
28/28 100%
Average
number
papil-
lomas
per
mouse
5.0±0.7
5-7±0-7
Average
latent
period
(weeks)
8
8
,, ·. 22/22 100% 4-3±0-*2 10
Tumours of lungs
Average
Mice number
bearing adenomas
adenomas/ per
survivors mouse
24/24 100% 7.0±0 9
26/28 93% 3-0±0.4
22/22 100% 4-8+0-6
Details of method, as in Table I, except for route of administration, as indicated above.
4. Comparisons with skin application (collar experiment)
Strict quantitative comparisons between the action of urethane by the
systemic routes and that resulting from direct skin application was impossible,
because of the difficulty in determining the proportion of the applied urethane
which is absorbed through the skin. There was, nevertheless, one important
aspect of the problem that had to be examined, namely, whether the urethane
applied to the skin surface did, in fact, penetrate at all, or whether its action
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depended on the substance being licked off and swallowed, thereafter acting
systemically.
To test this, a special plastic collar (Fig. 1) was designed, which would prevent
the mouse licking the painted area of skin or the paws that scratched that area.
[Preliminary tests, using a highly fluorescent hydrocarbon (3: 4-benzpyrene)
painted on the skin in mice with and without the collar, showed conclusively
that the procedure was adequate for preventing the applied material finding its
way to the system through the mouth. Fluorescence was readily observed in
the contents of the stomach, soon after the skin painting, in mice without the
collar, but no trace of fluorescence could be detected in those wearing it.]
Two groups ofmice were treated identically, receiving 4 twice-weekly paintings
of urethane to the skin, and later, repeated applications of croton oil according
to the standard procedure, except that one group was made to wear the collar
during the urethane treatment and for one week thereafter (by which time, all
the urethane on the skin would either have been absorbed, or would have
volatilized). Each mouse was kept in a separate cage during that period. The
results (Table IV) do not substantiate the idea that urethane only acted by mouth,
since both groups developed tumours of the skin and the lungs. However, the
number of tumours per animal was higher in the group without the collar, thus
indicating that some of the urethane, at least, normally reaches the systemic
circulation by the intestinal route, through licking.
TABLE IV.--Te8tfor Route of Action of Urethane when Applied Locally
to the Skin (Collar Experiment)
Tumours of lungs
Tumours of skin
Initiating -- Average
agent Mice Average Average Mice number
(urethane bearing number latent bearing adenomas
applied Promoting papillomas/ papillomas period adenomas/ per
to skin) agent survivors per mouse (weeks) survivors mouse
With collar Croton oil . 22/29 76% 1'0i0-3 141 . 14/29 48% 0-6±0-2
Without collar . ,, . 23/28 82% 1.7±0.3 10 25/28 89% 200-±03
* Urethane, 40 per cent in acetone, applied twice-weekly for two weeks, to the skin.
Interval between last application of urethane and first application of croton oil: 7 days.
Croton oil treatment, and other details of method, as in Table I.
5. Variations in interval between initiating and commencement ofpromoting action
A single dose of 25 mg. of urethane was given by mouth, as initiator, and
skin applications of croton oil, twice-weekly for 26 weeks, served as promotor,
the interval between the two, in the different groups, ranging from 30 minutes
to 56 days. The results (Table V) failed to show any striking difference in response
either in skin tumour or lung tumour incidence, or in the number of tumours
per animal, except for one case (56 days interval), in which the lung tumours per
animal were significantly higher than in any of the other groups.
EXPLANATION OF PLATE
FIG. 1.-Mouse wearing plastic collar to prevent it licking
the painted area of skin.
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In a second series, 50 mg. of urethane, injected subcutaneously, was followed
after 3 and 56 days, respectively, by the standard croton oil treatment on the
skin. In this series (Table V), the numniber of skin papillomas per animal was
somewhat higher in the case of the shorter than in that of the longer interval.
TABLEV.-Influence of Length of Interval Between Initiating Action and
Commencement of Promoting Action on Tumour Induction
Tumours of skin
r~~~
Mice Average Average
bearing number latent
papillomas/ papillomas period
survivors per mouse (weeks)
20/20 100% 3*1+0.4 9
18/20 90% 2-8±0-5 7
18/19 95% 3 0i0-4 9
16/19 84% 1-5±0-3 11
18/20 90% 1-5±0.5 11
33/40 82-5%1-6i0.2 11
36/38 94% 2.4±0.3 11
18/20 90% 2.4±0-4 11
34/37 92% 2.0±0-3 9
22/22 100% 4-3±0-2 10
16/20 80% 2.3i0.4 10
Tumours of lungs
Average
Mice number
bearing adenomas
adenomas/ per
survivors mouse
17/20 85% 2-7±0-5
16/20 80% 2*7+0- 5
15/19 80% 1-7i0-3
13/19 68% 2-2i0-6
12/20 60% 1.5+0.4
34/40 85% 2-7±0 3
28/38 74% 2-3i0-4
17/20 85% 2*4±0-3
35/37 94% 4-8i0- 6
22/22 100% 48±0- 6
18/20 90% 3-7i0 65
Details of method, as in Table I, except for injection by the subcutaneous route in the last two
experiments.
6. Influence of sex
Since both male and female mice were used in these experiments, some
information about the influence of sex on the present method of carcinogenesis
(for this particular strain of mice) might be obtained. Separate data for the two
sexes are not shown in Tables I-V, since the number of animals per group would
have been too small for statistical evaluation. Since a sex difference nevertheless
was suspected, on the groundsthatthe small observed differences were consistently
in the same direction, namely, towards a higher incidence for females, the figures
in Table V were pooled, and analysed according to sex, providing the following
results:
Average number papillomas per mouse: 2.7 0-2 for females; 1.7 + 0.2 for
males;
Average number of lung tumours per mouse: 3.5 ± 0.3 for females; 1.7 ± 0.2
for males.
These values are based on 96 females and 97 males.
7. Possible correlation between the induced tumours of the skin and lungs
In view of the double action of urethane-initiating action on the skin and
complete carcinogenic action on the lungs, and since, under the conditions of the
present experiments, the tumour yie]d in either tissue was often below 100 per
cent, it was interesting to determine whether there was any correlation between
responsiveness to one action and the other. No such correlation could be detected.
6
Initiating
agent
(urethane)
25 mg. per os
50 mg. s.c..
,,199
,,1 3
3,,191
50mg. s.c. .
,. .. 1)
Interval
I hour
3 hours
5
1 day
2 days
3 ,,
7 ,,
14 ,,
56 ,,
3 ,,
56 ,
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DISCUSSION
The two-stage mechanism of skin carcinogenesis postulates an initiating phase,
representing an irreversible transformation of some normal into "latent" or
"dormant" tumour cells, followed by a promoting phase, responsible for their
conversion into a growing tumour. This concept arose from certain experiments
in rabbits, in which tar-induced skin papillomas that had regressed, were made to
reappear by further treatment with a variety of stimuli (Rous and Kidd, 1941;
MacKenzie and Rous, 1941), and from subsequent experiments in mice, in which
applications of a carcinogen, insufficient to induce tumours, followed by croton
oil treatment, resulted in the appearance of papillomas (Berenblum, 1941;
Mottram, 1944; Berenblum and Shubik, 1947; etc.). In both types of experi-
ment, the agent used for initiating action was a complete carcinogen, the promot-
ing component being restricted by limiting the period of treatment (usually to
a single application, in the case of the mouse experiment).
Initiating action by the application of urethane to the mouse's skin (Graffi,
Vlamynch, Hoffmann, and Schulz, 1953; Salaman and Roe, 1953; Roe and
Salaman, 1954; Berenblum and Haran, 1955b) provided a refinement in the
technique, in that this compound is non-carcinogenic for mouse's skin, even when
applied twice-weekly for 43 weeks (Berenblum and Haran, 1955b), and also for
reasons already referred to in the introduction of this paper. The fact that
urethane also acted as an initiating agent for the mouse's skin when given by mouth
(Haran and Berenblum, 1956), provided certain new approaches to the study of
the mechanism of skincarcinogenesis, in that many of the side reactions, resulting
from local application of an initiating agent, were thereby eliminated.
The first stage of such a study must necessarily be concerned with comparisons
between the effectiveness of different routes of administration for systemic action,
and with the verification as to whether systemic initiating action was analogous to
that arising from local action on the skin. These investigations, reported here,
were carried out quantitatively, for additional information.
The fact that urethane given orally, intraperitoneally, and subcutaneously,
acted more or less equallyeffectively for initiating action on the skin (Experiment
3), eliminated the possibility that chemical changes in the gut, and absorption
through the intestinal mucosa, modified the effect in any way. The idea that
the urethane, applied to the skin, might act indirectly, by being first swallowed
through licking (Experiment 4)-an attractive possibility, in view of the absence
of any evidence of local irritation-was found to be untenable. Thus, whatever
the route by which the urethane enters the system (even by absorption through
the skin), it is capable ofacting both as an initiator for skin carcinogenesis and as
a complete carcinogen for the lung.
The fact that the tumour yield in the skin, resulting from a single feeding of
urethane followed by repeated local applications of croton oil to the skin, was
determined by the dose of urethane, while the average latent period was not
(Experiment 1), is in agreement with the earlier results involving local application
ofpolycyclic aromatic hydrocarbon carcinogens for initiating action (Berenblum
and Shubik, 1947), and fails to substantiate some recent criticisms regarding the
quantitative relationships of the two-stage mechanism of carcinogenesis. These
dealt with twoaspects oftheproblem-(a) concerning the quantitative correlation
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between dose of initiator and yield of tumours, and (b) concerning the lack of
correlation between dose of initiator and average latent period.
In a series of papers by Roe (1956a, 1956b) and Salaman and Roe (1956a,
1956b), experiments are described in which prolongation ofthe croton oil treatment
in the standard experiment (with local application of a hydrocarbon carcinogen
as initiator) led to a progressive increase in tumnour yield, which seemed contrary
to the levelling-off of the curves in the original experiments of Berenblum and
Shubik. Since both the carcinogen (used as initiator) and the croton oil (used as
promotor) may elicit some "background" carcinogenic action, it might be
expected that, after very prolonged treatment. additional tumours would appear
as a consequence of these complicating factors. The ideal set-up would be to
use a "pure" initiator and a "pure" promotor for testing the hypothesis. We
do not yet possess a pure promotor (i.e. completely lacking in initiating action),
though a pure initiator, in the form of urethane, is now available. The results
with urethane, described here, are consistent with the original hypothesis that
the number of tumours is a function of initiating action while the latent period
is a function of promoting action. Regarding the latter, the latent period
(Experiment 1) varied from group to group, without a consitent correlation with
the dose of initiator (as claimed by Klein, 1956).
A number of investigators (Graffi, 1953; Druckrey, 1954; Roe and Salaman,
1954; Klein, 1956) obtained a quantitatively cumulative effect when the same
amount of initiator is divided into separate doses; while some (e.g. Saffiotti and
Shubik, 1956) found the small, repeated doses actually more effective than the
large, single dose. The present results with urethane given orally (Experiment 2)
also suggest a cumulative effect, though not quantitatively. No explanation
is available to account for this, though the conditions of the experiment are
more complicated than might at first appear, since the dividing up ofthe dose into
several small doses also involves the spreading out of the initiating action over
a longer period.
SUMMARY
The previous observation that urethane, administered by mouth, acted as an
initiating agent for skin carcinogenesis in the mouse (i.e. rendering the skin
responsive to subsequent promoting action by locally applied croton oil, with the
development ofpapillomas) was confirmed. The intraperitoneal and subcutaneous
routes were found to be about equally effective.
The yield of skin papillomas, resulting from the initiating action of orally
administered urethane, followed by repeated skin applications of croton oil, was
determined by the dose of urethane adminstered (tested over a range of 1-64
mg.), while the average latent period was not related to dose. This result is in
keeping with the earlier findings of Berenblum and Shubik (1947), using 9: 10-
dimethyl-1 : 2-benzanthracene, applied locally, as initiator.
Varying the interval between the initiating action ofurethane (by mouth) and
the commencement of croton oil applications-tested over a range of 30 minutes
to 56 days-did not significantly affect the tumour yield in the skin.
By means of a special "collar" experiment, which prevented the mice from
licking the skin, it was possible to show thatlocally appliedurethane acted through
the skin rather than by being swallowed and absorbed through the intestine
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(though a slightly higher tumour yield was observed in mice that were allowed to
lick the skin).
The results are discussed in relation to other recent work on the "two-stage
mechanism" of skin carcinogenesis.
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